0001415889-24-006690.txt : 20240305
0001415889-24-006690.hdr.sgml : 20240305
20240305163306
ACCESSION NUMBER: 0001415889-24-006690
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 24721179
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-03052024_040331.xml
X0508
4
2024-03-01
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET
SILVER SPRING
MD
20910
true
true
false
false
CHAIRPERSON & CEO
1
Common Stock
2024-03-01
4
M
0
15000
129.49
A
15130
D
Common Stock
2024-03-01
4
S
0
1952
231.1102
D
13178
D
Common Stock
2024-03-01
4
S
0
5773
232.0355
D
7405
D
Common Stock
2024-03-01
4
S
0
4046
232.8691
D
3359
D
Common Stock
2024-03-01
4
S
0
987
234.3210
D
2372
D
Common Stock
2024-03-01
4
S
0
626
235.1312
D
1746
D
Common Stock
2024-03-01
4
S
0
1398
236.2389
D
348
D
Common Stock
2024-03-01
4
S
0
218
237.4609
D
130
D
Common Stock
2024-03-04
4
M
0
915
129.49
A
1045
D
Common Stock
2024-03-04
4
S
0
417
230.58
D
628
D
Common Stock
2024-03-04
4
S
0
7
231.39
D
621
D
Common Stock
2024-03-04
4
S
0
491
232.79
D
130
D
Stock Options
129.49
2024-03-01
4
M
0
15000
0
D
2014-12-31
2024-12-31
Common Stock
15000
708869
D
Stock Options
129.49
2024-03-04
4
M
0
915
0
D
2014-12-31
2024-12-31
Common Stock
915
707954
D
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
This transaction was executed in multiple trades at prices ranging from $230.49 to $231.475. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $231.52 to $232.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $232.58 to $233.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $233.62 to $234.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $234.81 to $235.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $235.86 to $236.8425. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $236.96 to $237.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $230.00 to $230.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $232.59 to $232.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/sA/ John S. Hess, Jr. under Power of Attorney
2024-03-05